These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 2983194)

  • 1. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
    Sugden B; Marsh K; Yates J
    Mol Cell Biol; 1985 Feb; 5(2):410-3. PubMed ID: 2983194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming functions associated with Epstein-Barr virus.
    Sugden B; Yates J; Mark W
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):82s-87s. PubMed ID: 6330229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
    Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
    Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.
    Sugden B; Warren N
    Mol Biol Med; 1988 Apr; 5(2):85-94. PubMed ID: 2840551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.
    Chittenden T; Lupton S; Levine AJ
    J Virol; 1989 Jul; 63(7):3016-25. PubMed ID: 2542609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Reisman D; Sugden B
    Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
    Lupton S; Levine AJ
    Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
    Yates J; Warren N; Reisman D; Sugden B
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3806-10. PubMed ID: 6328526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
    Gradoville L; Grogan E; Taylor N; Miller G
    Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Yates JL; Warren N; Sugden B
    Nature; 1985 Feb 28-Mar 6; 313(6005):812-5. PubMed ID: 2983224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immortalizing genes of Epstein-Barr virus.
    Middleton T; Gahn TA; Martin JM; Sugden B
    Adv Virus Res; 1991; 40():19-55. PubMed ID: 1659776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin.
    Little RD; Schildkraut CL
    Mol Cell Biol; 1995 May; 15(5):2893-903. PubMed ID: 7739569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term expression of a transferred gene in Epstein-Barr virus transformed human B cells.
    Shi GX; Wang Y; Liu Y; Cui W; Zhao FT; Zhu LP
    Scand J Immunol; 2001 Sep; 54(3):265-72. PubMed ID: 11555389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells.
    Margolskee RF; Kavathas P; Berg P
    Mol Cell Biol; 1988 Jul; 8(7):2837-47. PubMed ID: 2841588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged gene expression in primary porcine pancreatic cells using an Epstein-Barr virus-based episomal vector.
    Min KA; Oh ST; Yoon KH; Kim CK; Lee SK
    Biochem Biophys Res Commun; 2003 May; 305(1):108-15. PubMed ID: 12732203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EBV-based mammalian cell expression vector for efficient expression of cloned coding sequences.
    Jalanko A; Kallio A; Ruohonen-Lehto M; Söderlund H; Ulmanen I
    Biochim Biophys Acta; 1988 Feb; 949(2):206-12. PubMed ID: 2829966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
    Takada K; Ji Z; Fujiwara S; Shimizu N; Tanabe-Tochikura A
    J Virol; 1992 Sep; 66(9):5590-3. PubMed ID: 1323712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.